Annexin A4: A novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach

  • Li Ling Lin
  • , Chiung Nien Chen
  • , Wei Chou Lin
  • , Po Huang Lee
  • , King Jen Chang
  • , Yo Ping Lai
  • , Jin Town Wang
  • , Hsueh Fen Juan

Research output: Contribution to journalArticlepeer-review

Abstract

Helicobacter pylori was reported to be an important risk factor for the carcinogenesis of gastric cancer. Here, we used a proteomic approach to find differentially expressed proteins between the normal and tumor tissue of gastric cancer patients infected with H. pylori. In our results, we found annexin A4 was over-expressed in patients infected with H. pylori and was found in tumor cells, and over-expressed in gastric cancer SCM-1 cells after H. pylori infection. Ca2+ can be induced by H. pylori and interact with annexin A4 Ca2+ binding site to block the calmodulin-activated chloride conductance activation; therefore, it produces a new environment that benefits the malignant existence of H. pylori and raises the risk for gastric cancer. We also found interleuken-8 (IL-8) expression levels were increased in H. pylori infected SCM-1 cells. Combined with previous reports and our results, we summarize that the over-expression of annexin A4 in SCM-1 cells with H. pylori infection may subsequently induce IL-8 which can further cause tumor angiogenesis. In this paper, we show that annexin A4 is a potential novel molecular marker for gastric cancer with H. pylori infection, and our results may provide a new insight in the development of new anti-cancer drugs.

Original languageEnglish (US)
Pages (from-to)619-634
Number of pages16
JournalProteomics - Clinical Applications
Volume2
Issue number4
DOIs
StatePublished - Apr 2008
Externally publishedYes

Keywords

  • 2-DE
  • Annexin A4
  • Gastric cancer
  • Helicobactor pylori
  • Structure modeling

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Annexin A4: A novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach'. Together they form a unique fingerprint.

Cite this